A comprehensive view of Biopharmaceuticals / Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Efforts are ongoing to rescue gene therapy for rare disease ADA-SCiD; researchers at UCL and UCLA are developing the non-FDA approved simoladagene autotemcel therapy, supported by nonprofits
Published: July 26, 2024 by MarketLine
Bristol-Myers Squibb advances healthcare with CAR T therapy trials; company supports patient accessibility with travel aid for lupus study participants, emphasizing commitment to equitable treatment
Published: July 26, 2024 by Industry Intelligence Inc.
AbbVie gains European Commission approval for SKYRIZI® to treat moderate to severe ulcerative colitis in adults; supported by two pivotal Phase 3 trials showing clinical remission
Published: July 26, 2024 by AbbVie Inc.
Patent Issued for Anti-PDGF-B antibodies and pharmaceutical composition thereof (USPTO 12030935)
Published: July 26, 2024 by Disease Prevention Daily
Amgen Inc Applies for Patent on Adaptation of Platform Hosts to IGF -Media
Published: July 25, 2024 by Biotechnology Patent News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count